|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/00 |
| (11) | Number of the document | 2563391 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11716402.0 |
| Date of filing the European patent application | 2011-04-21 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/056461 |
| Date | 2011-04-21 |
| (87) | Number | WO 2011/134899 |
| Date | 2011-11-03 |
| (30) | Number | Date | Country code |
| 10161181 | 2010-04-27 | EP |
| (72) |
HERTING, Frank, DE
KLEIN, Christian, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren,
CH
|
| (54) | COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR |
| COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR |